SONX

Sonendo, Inc.
CAPPED RATING

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.

Sonendo, Inc. (SONX) is rated C (2.4/5) on Deltasharpe Prism, scored against General sector peers. Its strongest pillar is Momentum (A-); its weakest is Revisions (D+). The rating has held at C for 95 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.4 / 5.0
C
Value
C+
Factor Score 2.6 / 5.0
Growth
C-
Factor Score 2.0 / 5.0
Profitability
C-
Factor Score 2.0 / 5.0
Momentum
A-
Factor Score 4.0 / 5.0
Revisions
D+
Factor Score 1.5 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA N/A
Rev Growth YoY -0.1%
Gross Margin 41.1%
Price Return 3M 206.1%
Price Return 12M -12.2%
Catalyst Signal 0.00
Market Cap N/A
TTM Revenue N/A
Price / Sales 0.1
ROE -122.6%

Historical Factor Score Progression

Held C for 95 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-07-29 C+ (2.6) C- (2.0) C- (2.0) A- (4.0) D+ (1.5) C (2.4)
2024-12-31 C+ (2.6) C- (2.0) D+ (1.7) A- (3.9) D (1.5) C (2.4)
2024-09-30 C+ (2.6) C- (2.0) D+ (1.7) A- (3.9) D+ (1.5) C (2.3)
2024-06-30 C+ (2.6) C+ (2.5) C (2.2) A- (3.9) D (1.5) C+ (2.5)